This presentation delves into the critical challenges of bioassay development for multi-specific biologics, addressing key complexities. Experts from WuXi Biologics’ Bioassay Centre of Excellence (BCOE) showcase innovative strategies through real-world case studies, including the bioassay development of bispecific T-cell engagers and multi-specific probodies. Leveraging expertise in bioactivity method development, BCOE provides end-to-end CMC service and flexible standalone services…
Date:
More like thisRelated
RISK MANAGEMENT FROM RISK CONTROL TO GROWTH ENGINE
As organisations navigate an increasingly complex landscape shaped by...
60% of AU and SG brands missed their moment last year.
Klaviyo surveyed 400+ B2C marketers across Australia and Singapore...
AI hasn’t created “the AI shopper.” It’s created four.
Most brands are making a costly assumption: that their...
What is discounting actually costing ANZ brands?
ew research from marketing effectiveness expert James Hurman across...